ANDAORALTABLET
Approved
Oct 2024
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
9
Clinical Trials (5)
An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients
Started Oct 2013
96 enrolled
Renal Failure Chronic
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease
Started May 2012
101 enrolled
HyperphosphatemiaChronic Kidney Disease
Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Started Mar 2010
205 enrolled
Chronic Kidney DiseaseChronic Kidney Disease on Hemodialysis
Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
Started Feb 2009
349 enrolled
Kidney Failure, Chronic
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis
Started Jan 2009
5 enrolled
Chronic Kidney DiseaseHyperphosphatemia